Insulin therapy is recommended in women with GDM when MNT and self-blood glucose monitoring have not been adequate to maintain desirable plasma glucose levels (fasting: <105 mg/dl; 1-hour postprandial <155 mg/dl or 2-hour postprandial <130 mg/dL) and to prevent excessive maternal weight gain, macrosomia and fetal morbidity and mortality.